Plug and Play France is hosting its first Longevity morning in Paris on October 22, an invitation-only morning bringing together startups, investors and corporates (food & nutrition, beauty, insurance...) building the future of human healthspan.
Longevity innovation runs on data: biomarkers, wearables, biological age clocks, AI-driven discovery. We'll look at what comes after the data: who owns it, who gets to act on it, and what products it's already turning into.
The morning features selected startups turning biological data into prevention tools, new ingredients and new treatments, a panel discussion with corporates, startups and investors, and a networking breakfast.
Join us to connect with peers and innovators shaping the future of longevity.
Agenda
9:00 - 9:30: Welcome & breakfastFunctional wellness beverages by Kiisoku
9:30 - 9:50: The State of Longevity Innovation 2026Plug and Play presents its report mapping the ecosystem with 100+ startups analyzed and trends to watch across food, beauty, pharma, insurance and beyond.
9:50 - 10:10: Startup Pitches - From biology data to preventionHear from startups turning biological data into tools for healthspan prevention and risk prediction.
10:10 - 10:45: Networking breakCoffee break by Kiisoku
10:45 - 11:30 - Panel: What biological data actually changes in longevity innovation ? Corporate and startups perspectives on the biological data opportunity in longevity science.
11:30 - 11:45 : Startup Pitches - From discovery to treatmentHear from startups turning today's discoveries into new longevity ingredients, molecules, and treatments.
Panel
LVMH - Gérôme Guiot, Director Strategic Initiatives
Youngr Labs - Builds AI-powered virtual human cells to discover new drugs and identify anti-aging molecules focused on cellular rejuvenation.
LongeVC - An early-stage VC fund backing drug development, diagnostics, and infrastructure companies targeting the molecular and cellular mechanisms of aging.
Startups Pitching
Biolevate - AI knowledge platform for pharma, from regulatory document automation to accelerating drug discovery workflows.
Connectome - Building the world's largest brain data platform, turning fast, non-invasive brain scans into actionable biomarkers.
Sequential - The leading microbiome, genomics and multi-omics dataset for skin: 50K+ clinical samples to discover, and validate, next-generation bioactive ingredients for healthy ageing.
2nd Nature - AI platform mining agricultural byproducts to discover, develop and scale new natural ingredients.
Neotis - Developing T-cell engager immunotherapies for fibrotic disease, to bring a new class of therapeutics to age-related disease.
About Plug and Play
Plug and Play is one of the most active early-stage VCs globally, backing early-stage startups and running 100+ accelerator programs a year. Its ecosystem connects 550+ corporate partners with a network of 100,000+ startups across 60+ locations and 25+ verticals, and its portfolio includes 35+ unicorns, from PayPal to Dropbox.
